Celerion vs Sable Bio

Celerion vs Sable Bio, compared side by side on 18 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Celerion is on 59/100 and Sable Bio on 41/100.

Celerion logo
CelerionA global leader in clinical pharmacology and bioanalytical sciences.
Try Celerion
Sable Bio logo
Sable BioAI drug safety startup
Try Sable Bio

Where each one leads

Celerion

  • our overall score: 59/100 against 41/100
  • domain rating: 41/100 against 14/100
  • funding raised: $45.0M against $3.1M

Sable Bio

  • agent readiness: 44/100 against 38/100

At a glance

MeasureCelerionSable Bio
What it isA global leader in clinical pharmacology and bioanalytical sciences.AI drug safety startup
CategoryBiotechnology, Pharmaceuticals, Healthcare, Life SciencesBiotechnology, Artificial Intelligence, Drug Discovery, Pharmaceuticals
Sells toBusiness modelB2BB2B
OfferingServicesPlatform
Founded19752022
HeadquartersLincoln, USALondon, United Kingdom
StatusActiveActive

Size, funding and growth

MeasureCelerionSable Bio
Employees1,162Not published
Total funding$45.0M$3.1M
Latest roundMajority InvestmentUnknown
Valuation$1.1B$1.1B
LinkedIn followers26,451Not published

StartupHub scores

Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.

MeasureCelerionSable Bio
StartupHub scoreOur 0-100 rating59/10041/100
Traction58/10032/100
Team50/100Not published
Search visibility36/10011/100
Quality68/10058/100
Agent readinessHow well an AI agent can read and act on the siteF (38/100)D (44/100)
Domain ratingLink authority, 0-10041/10014/100

Technology

Detected on each public site, so it reflects the marketing stack as well as the product.

MeasureCelerionSable Bio
HostingSelf ManagedNot detected
CMSWordPressFramer
FrameworksJqueryNot detected
AnalyticsGoogle Tag ManagerGoogle Analytics 4

Celerion vs Sable Bio: common questions

Which is better, Celerion or Sable Bio?

On our 0-100 score Celerion rates higher (59/100 against 41/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 18 data points above: read the rows that match what you are buying for.

How do Celerion and Sable Bio compare on the numbers?

Celerion leads on our overall score (59/100 against 41/100), domain rating (41/100 against 14/100), funding raised ($45.0M against $3.1M). Sable Bio leads on agent readiness (44/100 against 38/100).

Read the full Celerion review and pricing or the Sable Bio review and pricing. You can also browse other Celerion alternatives we track.